What Novo Nordisk’s disappointing trial results mean for the obesity drug market
New clinical trial data from Novo Nordisk raise questions for the broad landscape of obesity drug development and the way investors view emerging candidates.
New clinical trial data from Novo Nordisk raise questions for the broad landscape of obesity drug development and the way investors view emerging candidates.
“This is a case of the general populace not being familiar with the density of air traffic in the national airspace, particularly on the Eastern…
Yehuda Handelsman, MD highlights insulin resistance’s role in cardiometabolic disease and introduces DCRM 2.0 as a global, multi-specialty care framework.
At The 2030 Playbook Conference – Strategies and Solutions for the Future of Healthcare, leaders will address how they plan to hit their five-year goals.
Narwhals have fascinated and confounded humans for centuries. The Peabody Essex Museum is diving into the mystery, history and science of the tusked “unicorns of…
A post for developers with advice and workflows for building effective AI agents
While there is an increasing interest in patient safety and in transforming safety culture in the perioperative environment, it is not clear what methods are…
Narwhals have fascinated and confounded humans for centuries. The Peabody Essex Museum is diving into the mystery, history and science of the tusked “unicorns of…
There’s a need for ongoing surveillance, preparedness and resources to confront this disease that disproportionately affects LGBTQ+ patients.
Angiomatoid fibrous histiocytoma (AFH) is a soft tissue tumour of intermediate (rarely metastasising) malignant potential, which harbours EWSR1/FUS gene fusions. These tumours can express anaplastic…
Findings point to lack of clarity on how diverse ecosystems were before they were lost to time, researchers say